Screener
Vaxcyte, Inc. PCVX Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001649094-26-000017
| Line item | March 31,2026 | December 31, 2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $260,843 | $173,959 |
| Short-term investments | 1,476,335 | 1,387,000 |
| Prepaid expenses and other current assets | 76,310 | 66,402 |
| Total current assets | 1,813,488 | 1,627,361 |
| Property and equipment, net | 260,695 | 257,370 |
| Operating lease right-of-use assets | 113,103 | 116,009 |
| Long-term investments | 1,004,017 | 881,664 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Vaxcyte, Inc.'s prepaid & other current?
- Vaxcyte, Inc. (PCVX) reported prepaid & other current of $76.31M in Q1 2026.
- How has Vaxcyte, Inc.'s prepaid & other current changed year-over-year?
- Vaxcyte, Inc.'s prepaid & other current increased by 70.2% year-over-year, from $44.83M to $76.31M.
- What is the long-term trend for Vaxcyte, Inc.'s prepaid & other current?
- Over 4 years (2021 to 2025), Vaxcyte, Inc.'s prepaid & other current has grown at a 46.7% compound annual growth rate (CAGR), from $47.76M to $221.43M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Vaxcyte, Inc.'s prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude